We are studying how CC-486 works in people with moderate or severe liver issues compared to those with normal liver function. This research aims to ensure safe and effective treatment options for cancer patients.
Health conditions and diseases that the clinical trial is designed to study and treat.
Myeloid malignancies are a group of blood cancers that affect the bone marrow and blood cells, leading to issues like anemia, infections, and bleeding. They include conditions such as chronic myelomonocytic leukemia and acute myelocytic leukemia, which can occur with varying degrees of liver function impairment.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.
